RegenoCell Therapeutics, Inc.(fka RCLL)

[trading.jeff]

RCLL FORM 12b-25:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8613294

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date;

...

The Registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 within the prescribed period because of a delay in completing the accounting for this period. Final accounting requires additional time to complete and incorporate in the Form 10 Q. Registrant expects to file within the extension period.

Five calendar days from today is Saturday, May 19; 10-Q will be filed on or before Monday, May 21, if I'm counting the days correctly (I don't know if today is the first day of the five or tomorrow is).